Login / Signup

Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study.

Cheryl J HartzellAlexandra SzabovaAndrew B CollinsArmand N MorelDesimir MijatovicKenneth R Goldschneider
Published in: Pediatric dermatology (2024)
Aprepitant shows promise in controlling refractory pruritus in pediatric EB and AD patients and deserves further study.
Keyphrases
  • atopic dermatitis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • patient reported outcomes
  • chemotherapy induced
  • deep learning